BG97059A - Имидазо (4,5-с) пиридини, антагонисти на раf - Google Patents

Имидазо (4,5-с) пиридини, антагонисти на раf

Info

Publication number
BG97059A
BG97059A BG097059A BG9705992A BG97059A BG 97059 A BG97059 A BG 97059A BG 097059 A BG097059 A BG 097059A BG 9705992 A BG9705992 A BG 9705992A BG 97059 A BG97059 A BG 97059A
Authority
BG
Bulgaria
Prior art keywords
pyridines
imidazo
raf antagonists
raf
antagonists
Prior art date
Application number
BG097059A
Other languages
English (en)
Inventor
Anthony Marfat
James EGGLER
Kevin Cooper
Michael Fray
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG97059A publication Critical patent/BG97059A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BG097059A 1990-05-09 1992-11-06 Имидазо (4,5-с) пиридини, антагонисти на раf BG97059A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09
PCT/US1991/002997 WO1991017163A1 (en) 1990-05-09 1991-05-01 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY

Publications (1)

Publication Number Publication Date
BG97059A true BG97059A (bg) 1993-12-24

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
BG097059A BG97059A (bg) 1990-05-09 1992-11-06 Имидазо (4,5-с) пиридини, антагонисти на раf

Country Status (28)

Country Link
EP (1) EP0533695B1 (bg)
JP (1) JPH0678340B2 (bg)
CN (1) CN1057839A (bg)
AP (1) AP224A (bg)
AT (1) ATE112567T1 (bg)
AU (1) AU642265B2 (bg)
BG (1) BG97059A (bg)
BR (1) BR9106433A (bg)
CA (1) CA2080476A1 (bg)
DE (1) DE69104481T2 (bg)
DK (1) DK0533695T3 (bg)
ES (1) ES2061247T3 (bg)
FI (1) FI925053A (bg)
GT (1) GT199100031A (bg)
HU (1) HUT62894A (bg)
IE (1) IE911553A1 (bg)
IL (1) IL98075A0 (bg)
MA (1) MA22151A1 (bg)
MY (1) MY105512A (bg)
NO (1) NO924290D0 (bg)
NZ (1) NZ238089A (bg)
PE (1) PE26691A1 (bg)
PT (1) PT97616A (bg)
RO (1) RO109450B1 (bg)
TW (1) TW205549B (bg)
WO (1) WO1991017163A1 (bg)
YU (1) YU81191A (bg)
ZA (1) ZA913497B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
WO1994004537A2 (en) * 1992-08-20 1994-03-03 Cytomed, Inc. Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
AU4183699A (en) * 1998-05-12 1999-11-29 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
US9725436B2 (en) 2013-09-13 2017-08-08 Cortendo Ab (Publ) Cytochrome P450 inhibitors and their method of use
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
YU81191A (sh) 1994-06-10
AU642265B2 (en) 1993-10-14
AP9100259A0 (en) 1991-07-31
HUT62894A (en) 1993-06-28
DE69104481T2 (de) 1995-02-09
EP0533695B1 (en) 1994-10-05
MY105512A (en) 1994-10-31
EP0533695A1 (en) 1993-03-31
IE911553A1 (en) 1991-11-20
NZ238089A (en) 1992-10-28
DE69104481D1 (de) 1994-11-10
IL98075A0 (en) 1992-06-21
NO924290L (no) 1992-11-06
NO924290D0 (no) 1992-11-06
HU9203496D0 (en) 1993-01-28
ATE112567T1 (de) 1994-10-15
ES2061247T3 (es) 1994-12-01
DK0533695T3 (da) 1995-01-09
AU7867191A (en) 1991-11-27
FI925053A0 (fi) 1992-11-06
FI925053A (fi) 1992-11-06
WO1991017163A1 (en) 1991-11-14
JPH05505619A (ja) 1993-08-19
CA2080476A1 (en) 1991-11-10
PE26691A1 (es) 1991-10-21
RO109450B1 (ro) 1995-02-28
AP224A (en) 1992-10-27
CN1057839A (zh) 1992-01-15
GT199100031A (es) 1992-10-30
MA22151A1 (fr) 1991-12-31
BR9106433A (pt) 1993-05-04
TW205549B (bg) 1993-05-11
ZA913497B (en) 1992-12-30
JPH0678340B2 (ja) 1994-10-05
PT97616A (pt) 1992-03-31

Similar Documents

Publication Publication Date Title
DE69003575D1 (de) Formulierung, ein imidazo(4,5-c)quinolin-derivat enthaltend.
DE69011914D1 (de) Olefinisch substitierte 1H-Imidazo[4,5-c]chinolin-4-amine.
NO811058L (no) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-on-derivater
MA19513A1 (fr) Nouvelles imidazo (1,2-a) pyridines et pyrazines
DK608887D0 (da) Imidazopyridinderivater
DK495287D0 (da) 2-eller 3-arylsubstituerede imidazo(1,2-a)pyridi ner
BG95241A (bg) Метод за получаване на 2,9-дизаместени-4н-пиридо/1.2-а/ пиримидин-4-они
DK530888A (da) Leukotrien -ltd4- og - ltb4-antagonister
BG97059A (bg) Имидазо (4,5-с) пиридини, антагонисти на раf
DK0384522T3 (da) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2-thioner
FI903276A0 (fi) Cigarettstaenger med flytande flavoer i mitten.
DE3376324D1 (de) Imidazo(1,5-a)pyridine derivatives
EP0417760A3 (en) Phenylalkanoyl substituted imidazo(4,5-c) pyridines
FI893605A0 (fi) Imidatso (4,5-b) pyridinderivat.
IT8021821A0 (it) Pirido [1,2-a] pirimidine sostituite
NO895217D0 (no) Substituerte pyrido(2,3-d)pyrimidiner.
FI906270A (fi) Imidazo/4,5-c/pyridiner som antiosteoporotiska aemnen.
DK91989D0 (da) Bensofuro(3,2-c)quinolinforbindelser
DE3682244D1 (de) Substituierte dihydroimidazo(1,2-a)chinoxalinderivate.
DE3267918D1 (de) Pyrazolo(3,4-b)pyridine derivatives
DE3875030D1 (de) Leukotrien-antagonisten.
FI940607A0 (fi) Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina
FI930108A0 (fi) Imidazopyridin-paf-antagonister
FI845085A0 (fi) Nya imidazo/4,5-c/pyridin-oner, deras framstaellning och dessa foereningar innehaollande laekemedel.
DK161328C (da) 2-phenylpyrano(2,3-b)pyridiner